These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 16869242)

  • 1. Upregulation of the oncogenic helix-loop-helix protein Id2 in Ewing sarcoma.
    Park HR; Jung WW; Kim HS; Santini-Araujo E; Kalil RK; Bacchini P; Bertoni F; Unni KK; Park YK
    Tumori; 2006; 92(3):236-40. PubMed ID: 16869242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma.
    Fukuma M; Okita H; Hata J; Umezawa A
    Oncogene; 2003 Jan; 22(1):1-9. PubMed ID: 12527902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.
    Yoshida A; Sekine S; Tsuta K; Fukayama M; Furuta K; Tsuda H
    Am J Surg Pathol; 2012 Jul; 36(7):993-9. PubMed ID: 22446943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
    Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
    Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ewing sarcoma: a chronicle of molecular pathogenesis.
    Kim SK; Park YK
    Hum Pathol; 2016 Sep; 55():91-100. PubMed ID: 27246176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma.
    Puls F; Niblett A; Marland G; Gaston CL; Douis H; Mangham DC; Sumathi VP; Kindblom LG
    Am J Surg Pathol; 2014 Oct; 38(10):1307-18. PubMed ID: 24805859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The helix-loop-helix protein Id2 is expressed differentially and induced by myc in T-cell lymphomas.
    Cotta CV; Leventaki V; Atsaves V; Vidaki A; Schlette E; Jones D; Medeiros LJ; Rassidakis GZ
    Cancer; 2008 Feb; 112(3):552-61. PubMed ID: 18085637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitor of DNA binding 2 (ID2) regulates the expression of developmental genes and tumorigenesis in ewing sarcoma.
    Koppenhafer SL; Goss KL; Voigt E; Croushore E; Terry WW; Ostergaard J; Gordon PM; Gordon DJ
    Oncogene; 2022 May; 41(20):2873-2884. PubMed ID: 35422476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?
    Zoubek A; Dockhorn-Dworniczak B; Delattre O; Christiansen H; Niggli F; Gatterer-Menz I; Smith TL; Jürgens H; Gadner H; Kovar H
    J Clin Oncol; 1996 Apr; 14(4):1245-51. PubMed ID: 8648380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of Id helix-loop-helix proteins in colorectal adenocarcinoma correlates with p53 expression and mitotic index.
    Wilson JW; Deed RW; Inoue T; Balzi M; Becciolini A; Faraoni P; Potten CS; Norton JD
    Cancer Res; 2001 Dec; 61(24):8803-10. PubMed ID: 11751402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
    Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
    Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional, chemical genomic, and super-enhancer screening identify sensitivity to cyclin D1/CDK4 pathway inhibition in Ewing sarcoma.
    Kennedy AL; Vallurupalli M; Chen L; Crompton B; Cowley G; Vazquez F; Weir BA; Tsherniak A; Parasuraman S; Kim S; Alexe G; Stegmaier K
    Oncotarget; 2015 Oct; 6(30):30178-93. PubMed ID: 26337082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining Ewing and Ewing-like small round cell tumors (SRCT): The need for molecular techniques in their categorization and differential diagnosis. A study of 200 cases.
    Machado I; Navarro L; Pellin A; Navarro S; Agaimy A; Tardío JC; Karseladze A; Petrov S; Scotlandi K; Picci P; Llombart-Bosch A
    Ann Diagn Pathol; 2016 Jun; 22():25-32. PubMed ID: 27180056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing Sarcoma.
    Agelopoulos K; Richter GH; Schmidt E; Dirksen U; von Heyking K; Moser B; Klein HU; Kontny U; Dugas M; Poos K; Korsching E; Buch T; Weckesser M; Schulze I; Besoke R; Witten A; Stoll M; Köhler G; Hartmann W; Wardelmann E; Rossig C; Baumhoer D; Jürgens H; Burdach S; Berdel WE; Müller-Tidow C
    Clin Cancer Res; 2015 Nov; 21(21):4935-46. PubMed ID: 26179511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Id2 protein is selectively upregulated by UVB in primary, but not in immortalized human keratinocytes and inhibits differentiation.
    Simbulan-Rosenthal CM; Trabosh V; Velarde A; Chou FP; Daher A; Tenzin F; Tokino T; Rosenthal DS
    Oncogene; 2005 Aug; 24(35):5443-58. PubMed ID: 16007217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
    Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
    PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma.
    Sand LGL; Buckle T; van Leeuwen FWB; Corver WE; Kruisselbrink AB; Jochemsen AG; Hogendoorn PCW; Szuhai K
    BMC Cancer; 2017 May; 17(1):383. PubMed ID: 28549419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An unusual association of malignant gastrointestinal neuroectodermal tumor (clear cell sarcoma-like) and Ewing sarcoma.
    Insabato L; Guadagno E; Natella V; Somma A; Bihl M; Pizzolorusso A; Mainenti PP; Apice G; Tornillo L
    Pathol Res Pract; 2015 Sep; 211(9):688-92. PubMed ID: 26163185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.